ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

NIH Negotiating On Straus Grant; Committee Asks for One Probe

July 17, 1981

AACR Grant Programs. NIH RFA Available.

June 29, 2001

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

July 10, 1992

FDA To Expand Disclosure For Advisory Committee Members

April 23, 2010

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

World Conference To Consider Smoking Problem, Research, Action

March 14, 1975